Sight Ebitda vs Cost Of Revenue Analysis

SGHT Stock

USD 4.01 0.25 6.65%

Sight Sciences financial indicator trend analysis is much more than just breaking down Sight Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sight Sciences is a good investment. Please check the relationship between Sight Sciences Ebitda and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sight Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Sight Stock please use our How to Invest in Sight Sciences guide.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sight Sciences Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Sight Sciences' Ebitda and Cost Of Revenue is -0.92. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Sight Sciences, assuming nothing else is changed. The correlation between historical values of Sight Sciences' Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Sight Sciences are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Sight Sciences' Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.92

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Sight Sciences income statement and represents the costs associated with goods and services Sight Sciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Sight Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sight Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sight Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Sight Stock please use our How to Invest in Sight Sciences guide.Sales General And Administrative To Revenue is likely to gain to 1.65 in 2024, whereas Tax Provision is likely to drop slightly above 74.8 K in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	40.3M	59.0M	69.2M	38.3M
Total Revenue	49.0M	71.3M	81.1M	47.6M

Gross Profit Total Revenue

Sight Sciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.92	0.93	0.93	0.98	0.91	0.88	-0.99	-0.82	0.82	1.0	0.87	0.58	0.64	1.0	0.87	0.89	0.81	0.02	0.82	0.99	0.96	0.16	0.96	0.82	1.0
Other Current Liab	0.92		1.0	0.77	0.9	0.77	0.93	-0.87	-0.85	0.75	0.9	0.91	0.61	0.77	0.9	0.93	0.83	0.9	0.22	0.87	0.89	0.91	0.36	0.83	0.83	0.92
Total Current Liabilities	0.93	1.0		0.79	0.92	0.8	0.95	-0.88	-0.88	0.74	0.92	0.94	0.66	0.77	0.92	0.95	0.86	0.91	0.2	0.9	0.9	0.94	0.34	0.85	0.88	0.93
Total Stockholder Equity	0.93	0.77	0.79		0.87	0.95	0.75	-0.95	-0.73	0.73	0.93	0.73	0.4	0.33	0.93	0.79	0.87	0.59	-0.34	0.72	0.96	0.9	-0.21	0.99	0.72	0.93
Other Liab	0.98	0.9	0.92	0.87		0.86	0.89	-0.95	-0.83	0.75	0.98	0.9	0.66	0.74	0.98	0.87	0.87	0.85	0.15	0.85	0.96	0.96	0.28	0.91	0.86	0.98
Net Tangible Assets	0.91	0.77	0.8	0.95	0.86		0.79	-0.92	-0.87	0.67	0.9	0.78	0.64	0.4	0.9	0.83	0.97	0.68	-0.3	0.79	0.92	0.91	-0.17	0.95	0.8	0.91
Property Plant And Equipment Net	0.88	0.93	0.95	0.75	0.89	0.79		-0.83	-0.87	0.7	0.87	0.99	0.71	0.74	0.87	0.92	0.86	0.96	0.19	0.92	0.83	0.89	0.32	0.81	0.95	0.88
Net Debt	-0.99	-0.87	-0.88	-0.95	-0.95	-0.92	-0.83		0.77	-0.86	-0.99	-0.8	-0.5	-0.54	-0.99	-0.81	-0.88	-0.74	0.07	-0.74	-0.99	-0.92	-0.06	-0.97	-0.75	-0.99
Retained Earnings	-0.82	-0.85	-0.88	-0.73	-0.83	-0.87	-0.87	0.77		-0.48	-0.79	-0.9	-0.88	-0.67	-0.79	-0.94	-0.96	-0.84	-0.03	-0.95	-0.8	-0.91	-0.15	-0.78	-0.92	-0.82
Accounts Payable	0.82	0.75	0.74	0.73	0.75	0.67	0.7	-0.86	-0.48		0.84	0.64	0.26	0.48	0.84	0.52	0.61	0.67	0.11	0.42	0.8	0.64	0.21	0.75	0.49	0.82
Cash	1.0	0.9	0.92	0.93	0.98	0.9	0.87	-0.99	-0.79	0.84		0.85	0.55	0.63	1.0	0.85	0.88	0.8	0.01	0.79	0.99	0.95	0.15	0.96	0.8	1.0
Non Current Assets Total	0.87	0.91	0.94	0.73	0.9	0.78	0.99	-0.8	-0.9	0.64	0.85		0.77	0.78	0.85	0.93	0.86	0.97	0.22	0.94	0.82	0.9	0.35	0.79	0.98	0.87
Non Currrent Assets Other	0.58	0.61	0.66	0.4	0.66	0.64	0.71	-0.5	-0.88	0.26	0.55	0.77		0.75	0.55	0.72	0.78	0.79	0.29	0.8	0.53	0.69	0.37	0.47	0.81	0.57
Other Assets	0.64	0.77	0.77	0.33	0.74	0.4	0.74	-0.54	-0.67	0.48	0.63	0.78	0.75		0.63	0.68	0.55	0.88	0.74	0.71	0.57	0.66	0.82	0.43	0.71	0.64
Cash And Short Term Investments	1.0	0.9	0.92	0.93	0.98	0.9	0.87	-0.99	-0.79	0.84	1.0	0.85	0.55	0.63		0.85	0.88	0.8	0.01	0.79	0.99	0.95	0.15	0.96	0.8	1.0
Net Receivables	0.87	0.93	0.95	0.79	0.87	0.83	0.92	-0.81	-0.94	0.52	0.85	0.93	0.72	0.68	0.85		0.9	0.84	0.05	0.98	0.86	0.96	0.19	0.84	0.93	0.87
Common Stock Total Equity	0.89	0.83	0.86	0.87	0.87	0.97	0.86	-0.88	-0.96	0.61	0.88	0.86	0.78	0.55	0.88	0.9		0.78	-0.14	0.88	0.89	0.93	-0.02	0.9	0.87	0.89
Common Stock Shares Outstanding	0.81	0.9	0.91	0.59	0.85	0.68	0.96	-0.74	-0.84	0.67	0.8	0.97	0.79	0.88	0.8	0.84	0.78		0.43	0.86	0.74	0.81	0.55	0.67	0.9	0.81
Non Current Liabilities Total	0.02	0.22	0.2	-0.34	0.15	-0.3	0.19	0.07	-0.03	0.11	0.01	0.22	0.29	0.74	0.01	0.05	-0.14	0.43		0.1	-0.07	0.0	0.99	-0.24	0.12	0.02
Inventory	0.82	0.87	0.9	0.72	0.85	0.79	0.92	-0.74	-0.95	0.42	0.79	0.94	0.8	0.71	0.79	0.98	0.88	0.86	0.1		0.79	0.93	0.23	0.77	0.97	0.81
Other Current Assets	0.99	0.89	0.9	0.96	0.96	0.92	0.83	-0.99	-0.8	0.8	0.99	0.82	0.53	0.57	0.99	0.86	0.89	0.74	-0.07	0.79		0.96	0.06	0.98	0.78	0.99
Other Stockholder Equity	0.96	0.91	0.94	0.9	0.96	0.91	0.89	-0.92	-0.91	0.64	0.95	0.9	0.69	0.66	0.95	0.96	0.93	0.81	0.0	0.93	0.96		0.14	0.94	0.9	0.96
Total Liab	0.16	0.36	0.34	-0.21	0.28	-0.17	0.32	-0.06	-0.15	0.21	0.15	0.35	0.37	0.82	0.15	0.19	-0.02	0.55	0.99	0.23	0.06	0.14		-0.11	0.24	0.15
Net Invested Capital	0.96	0.83	0.85	0.99	0.91	0.95	0.81	-0.97	-0.78	0.75	0.96	0.79	0.47	0.43	0.96	0.84	0.9	0.67	-0.24	0.77	0.98	0.94	-0.11		0.77	0.96
Property Plant And Equipment Gross	0.82	0.83	0.88	0.72	0.86	0.8	0.95	-0.75	-0.92	0.49	0.8	0.98	0.81	0.71	0.8	0.93	0.87	0.9	0.12	0.97	0.78	0.9	0.24	0.77		0.82
Total Current Assets	1.0	0.92	0.93	0.93	0.98	0.91	0.88	-0.99	-0.82	0.82	1.0	0.87	0.57	0.64	1.0	0.87	0.89	0.81	0.02	0.81	0.99	0.96	0.15	0.96	0.82

Click cells to compare fundamentals

Sight Sciences Account Relationship Matchups

Sight Sciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.7M	72.8M	280.2M	213.1M	166.7M	141.5M
Other Current Liab	4.5M	6.8M	9.6M	14.1M	7.7M	8.0M
Total Current Liabilities	7.3M	9.3M	13.5M	17.8M	12.3M	11.6M
Total Stockholder Equity	(54.7M)	(88.8M)	232.1M	160.1M	120.2M	62.3M
Other Liab	213K	809K	1.9M	1.2M	1.4M	919.6K
Net Tangible Assets	(54.7M)	(88.8M)	232.1M	160.1M	184.1M	193.3M
Property Plant And Equipment Net	2.6M	1.8M	2.9M	3.2M	3.1M	2.7M
Net Debt	(7.3M)	(29.0M)	(228.0M)	(150.7M)	(102.7M)	(107.9M)
Retained Earnings	(55.3M)	(90.0M)	(153.0M)	(239.2M)	(294.8M)	(280.1M)
Accounts Payable	2.3M	2.2M	3.4M	2.7M	1.7M	2.6M
Cash	21.2M	61.5M	260.7M	185M	138.1M	123.0M
Non Current Assets Total	2.7M	2.2M	3.2M	3.4M	3.8M	3.0M
Non Currrent Assets Other	168K	386K	202K	211K	682K	716.1K
Other Assets	168K	386K	202K	211K	242.7K	226.4K
Cash And Short Term Investments	21.2M	61.5M	260.7M	185M	138.1M	123.0M
Net Receivables	4.1M	5.4M	8.7M	15.1M	14.3M	9.1M
Liabilities And Stockholders Equity	30.7M	72.8M	280.2M	213.1M	166.7M	141.5M
Non Current Liabilities Total	78.1M	152.3M	34.6M	35.2M	34.2M	49.1M
Capital Lease Obligations	1.1M	529K	1.6M	1.7M	1.5M	1.2M
Inventory	2.2M	2.6M	3.5M	6.1M	7.8M	4.2M
Other Current Assets	426K	1.2M	4.2M	3.4M	2.6M	2.3M
Other Stockholder Equity	656K	120.6M	385.1M	399.3M	415.0M	242.2M
Total Liab	85.4M	161.7M	48.1M	53.0M	46.4M	57.6M
Net Invested Capital	(41.8M)	(56.9M)	264.8M	193.4M	154.1M	88.8M
Property Plant And Equipment Gross	2.6M	1.8M	2.9M	3.2M	4.7M	2.9M
Total Current Assets	28.0M	70.6M	277.0M	209.7M	162.9M	138.5M
Net Working Capital	20.7M	61.3M	263.5M	191.9M	150.6M	126.9M
Property Plant Equipment	2.6M	1.8M	2.9M	1.6M	1.8M	2.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC